Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proarrhythmia.

G V Naccarelli1, D L Wolbrette, J C Luck

  • 1Department of Medicine, Pennsylvania State University College of Medicine, Milton Hershey Medical Center, Hershey, Pennsylvania, USA.

The Medical Clinics of North America
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.

Journal of internal medicine·2007
Same author

Report of the NASPE policy conference on arrhythmias and the athlete.

Journal of cardiovascular electrophysiology·2001
Same author

Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation.

Pacing and clinical electrophysiology : PACE·2001
Same author

Reprocessing of electrophysiology catheters: clinical studies, regulations, and recommendations. A report of the NASPE Task Force on Reprocessing of Electrophysiological Catheters. North American Society of Pacing and Electrophysiology.

Pacing and clinical electrophysiology : PACE·2001
Same author

Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2001
Same author

The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities.

The American journal of medicine·2001
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Antiarrhythmic drugs can worsen existing heart rhythms or cause new ones, leading to proarrhythmia. This review covers the incidence, risk factors, and management of these dangerous drug-induced arrhythmias.

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Proarrhythmia is a significant concern in antiarrhythmic drug therapy.
  • It involves the worsening or induction of cardiac arrhythmias by medications.
  • This can range from bradyarrhythmias to life-threatening ventricular tachycardias.

Purpose of the Study:

  • To review the incidence of proarrhythmic events.
  • To identify aggravating factors contributing to proarrhythmia.
  • To discuss current treatment strategies for proarrhythmia.

Main Methods:

  • Literature review of proarrhythmia.
  • Analysis of drug-induced arrhythmias.
  • Synthesis of data on incidence, risk factors, and treatment.

Related Experiment Videos

Main Results:

  • Proarrhythmic events encompass bradyarrhythmias and atrial/ventricular arrhythmias.
  • New onset ventricular tachycardia and Torsade de Pointes are critical concerns.
  • Incidence and specific aggravating factors are detailed.

Conclusions:

  • Understanding proarrhythmia is crucial for safe antiarrhythmic drug use.
  • Early recognition and management of proarrhythmic events are essential.
  • Further research into risk stratification and prevention is warranted.